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Overview 
 Work in progress on several disparate themes 
 But in common - whether future technology will force a 
change of current paradigms in first-party relationships 
between physician-patient, and researcher-subject: 
 Disclosure in the physician-patient relationship 
 The limits of the duty of care of physicians in 
relation to holdings of genetic data 
 Any different for researchers? 
  And in third-party relationships: 
 Is there a duty to warn 3rd parties? 
 Implications for the future development of medical 
confidentiality 
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The Liability of Physicians 
 The Agreement 
 Easy to sequence 
 But hard to interpret … 
 ... and expensive. 
 So prudence dictates contractual limitation 
 Unknowns  and current technological limits 
favour the physician - causation 
 But can contract override tort?  Especially 
where physical harm / injury / death in issue? 
3 
The Liability of Physicians 
 Disclosure 
 Used to be simple. 
 But not after Montgomery  Lanarkshire 
Health Board [2015] UKSC 11 
 Bolam shaken and restricted – duty of 
disclosure brought in line with Australian, NZ, 
Canadian approaches – logical refresh 
necessitated by rise of autonomy principle 
 But other substantive changes under the hood 
may have greater impact down the road? – 
Montgomery: ‘doctor’s advisory role involves 
dialogue’ [90] 
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The Liability of Physicians 
 Disclosure 
 Continuing dialogue:  if duty no longer liminal, 
what are its limits? 
 A glass very darkly for now:  but 10 years down 
the road, technology makes possible and 
commonplace analyses not possible now 
 And give rise to new professional standards of 
prudence / good practice / SoPs 
 Will it be a defence in 10 years time, if 
automated periodic screening of electronic 
medical and genetic records become routine – 
like screening for computer viruses is now? 
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The Liability of Physicians 
 Dialogue 
 But this is just the ground floor? With advent 
of cheap sequencing, inevitable that WGS 
becomes universal first / basic procedure (like 
asking for family history is now)  
 Problem:  Genomic data is qualitatively 
different from other clinical data, which are 
essentially snapshots of physiological function 
at particular point in time, may be predictively 
unreliable, subject to false negatives / 
positives, open to interpretation.  But your 
book of life is definitive.  
 What is not possible / reliable / known now 
will in the future be otherwise 
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And of Researchers & Data Holders 
 And data holders? 
 And researchers?   Current refuge in arguments will 
fail in the future because of the certain and 
immutable nature of WGS data – it will be the same 
book read by clinicians 
 Beyond WGS:  epigenetics and human microbiomics 
 Cautionary tale for data holders:  in future, access 
and control of genetic data may come with legal 
responsibilities that blur the liability lines between 
physicians, researchers and data holders 
 Montgomery still stuck on paradigm of a one-to-one 
physician-patient relationship in the law, but 
completely unreal in the context of HMOs, insurers, 
employers paying health benefits, the NHS? 
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And of Researchers & Data Holders 
 As in medical negligence in England (and followers of 
Bolam), the liability battleground may shift  to a 
reconsideration of the principles of causation and 
remoteness – where English common law has showed 
no reluctance in reworking liability in cases where 
physical harm or disease is in issue (e.g. Fairchild v 
Glenhaven, Chester v Afshar) 
 But the law would also have to review its fundamental 
approach to the duty of care in negligence of parties 
other than physicians having a hand in the care of 
patients – and of their genetic data.  Coming up … 
8 
Third Parties 
 Do third parties have a right to be warned of genetic 
vulnerabilities? 
 Current English law on medical confidentiality 
premised on AG v Guardian No 2, W v Egdell, X v 
Bedfordshire CC etc – confidentiality not a legal 
privilege, a bare presumption in the public interest 
(not private interest) aimed at fostering full disclosure 
by patient to benefit of patient 
 American developments such as Tarasoff  v UCLA 
studiously ignored – liability for not disclosing threat 
of harm to 3P 
9 
Third Parties 
 But main difference:  genetic threats are not external 
threats – they are inherent threats in every sense of 
the word 
 They are also shared 
 But first shot across bow:  ABC v St George’s 
Healthcare Trust [2015] EWHC 1394 (QB) 
 No doubt first of many. Huntington’s - incremental 
approach to duty of care in Caparo v Dickman 
[1990] 2 AC 605 insisted on 
 Claimant in ABC had to demonstrate that her claim 
could fit into an existing category of duty of care – or 
that her case was of that kind that merited an 
incremental expansion of an existing category – 
unlike previous Anns v Merton approach 
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Third Parties 
 Current approach therefore denies possibility of 
entirely new categories – at odds with reality? 
 But Caparo and its ilk deal with claims for pure 
economic loss – product of judicial concern for 
commercial certainty? – underlying policy 
considerations for  the ‘closed categories’ approach in 
Caparo does not fit reality well 
 Ethical codes around the world (GMC, HKMA etc) 
recognize that exceptions to confidentiality duty may 
be made on grounds of public safety , prevention of 
crime etc 
 Is an inherent genetic risk to health or life any 
different? 
 One difficulty:  the right not to know 
11 
Third Parties 
 Relational information:  as healthcare IT systems 
move towards large-scale integration, what kind of 
liabilities may emerge from mere fact of possession 
or holding of information of many related persons? 
 Working backwards:  good to warn if we spot 
patterns in segment of general population, but as 
both segment and general population size decreases?  
What point does demands of privacy come into play? 
 Shared information: Essential problem with genetic 
information is that is is by definition shared 
information – it is not wholly your own 
 What common rights have groups of related 
individuals to this shared inheritance (which may be 
of commercial value)? 
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Third Parties 
 What restrictions on individual rights if common 
shared rights of group is accepted? 
 Return of benefits?  Echoes of HUGO Ethics 
Committee - Statement on Benefit Sharing 
 Consider:  X., one of two identical twins, ‘donates’ 
his entire genome to science. What rights has Y. his 
identical twin? 
 Ragnhildur Guðmundsdóttir v Iceland (2003) 
Supreme Court of Iceland (No 151/2003) – Health 
Sector Database Act successfully challenged 
 Do current legal privacy paradigms premised on 
individual rights fit well with biological reality? 
13 
The Point of Privacy 
 Nosy relatives and over-eager clinicians and 
researchers may be the least of your problems in the 
future:  privacy laws have never deterred rogue states 
(and state entities), terrorists, criminals – and most 
of all commercial interests – from acquiring 
desirable or useful personal information 
 The law is going to find it hard to catch up with 
future technology that allows sequencing from the 
tiniest traces of yourself 
 The danger is that privacy paradigms for the future is 
driven by such concerns rather than the ultimate 
raison d’etre for the concept of privacy:  dignity and 
welfare of the individual. 
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